These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28969959)

  • 1. Impact of chemotherapy-associated liver injury on tumour regression grade and survival in patients with colorectal liver metastases.
    Zhao J; Sawo P; Rensen SS; Rouflart MMJ; Winstanley A; Vreuls CPH; Verheij J; van Mierlo KMC; Lodewick TM; van Woerden V; van Tiel FH; van Dam RM; Dejong CHC; Olde Damink SWM
    HPB (Oxford); 2018 Feb; 20(2):147-154. PubMed ID: 28969959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
    Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
    Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversibility of chemotherapy-related liver injury.
    Vigano L; De Rosa G; Toso C; Andres A; Ferrero A; Roth A; Sperti E; Majno P; Rubbia-Brandt L
    J Hepatol; 2017 Jul; 67(1):84-91. PubMed ID: 28284915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
    Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
    HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases.
    Zhao J; van Mierlo KMC; Gómez-Ramírez J; Kim H; Pilgrim CHC; Pessaux P; Rensen SS; van der Stok EP; Schaap FG; Soubrane O; Takamoto T; Viganò L; Winkens B; Dejong CHC; Olde Damink SWM;
    Br J Surg; 2017 Jul; 104(8):990-1002. PubMed ID: 28542731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.
    Brouquet A; Benoist S; Julie C; Penna C; Beauchet A; Rougier P; Nordlinger B
    Surgery; 2009 Apr; 145(4):362-71. PubMed ID: 19303984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.
    Hubert C; Lucidi V; Weerts J; Dili A; Demetter P; Massart B; Komuta M; Navez J; Reding R; Gigot JF; Sempoux C
    Eur J Surg Oncol; 2018 Oct; 44(10):1532-1538. PubMed ID: 30093084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: A systematic review with meta-analysis.
    van Mierlo KM; Zhao J; Kleijnen J; Rensen SS; Schaap FG; Dejong CH; Olde Damink SW
    Surg Oncol; 2016 Sep; 25(3):298-307. PubMed ID: 27566036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
    Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
    J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
    Berardi G; De Man M; Laurent S; Smeets P; Tomassini F; Ariotti R; Hoorens A; van Dorpe J; Varin O; Geboes K; Troisi RI
    Eur J Surg Oncol; 2018 Jul; 44(7):1069-1077. PubMed ID: 29615295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM).
    Saez-Carlin P; García-Botella A; Diez-Valladares LI; Ortega Medina L; Méndez R; González JCM; Bernal I; Serrano García I; Avellana R; Torres García AJ
    Clin Transl Oncol; 2020 Jul; 22(7):1180-1186. PubMed ID: 31758496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Strategy Based on Indocyanine Green Test for Chemotherapy-Associated Liver Injury and Long-Term Outcome in Colorectal Liver Metastases.
    Takamoto T; Hashimoto T; Ichida A; Shimada K; Maruyama Y; Makuuchi M
    J Gastrointest Surg; 2018 Jun; 22(6):1077-1088. PubMed ID: 29488125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy.
    Chang HH; Leeper WR; Chan G; Quan D; Driman DK
    Am J Surg Pathol; 2012 Apr; 36(4):570-6. PubMed ID: 22301494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological response of colorectal liver metastases treated after induction treatment.
    Ben Slama S; Bacha D; Sassi A; Khadhar A; Bayar R; Bouraoui S; Lahmar A
    Tunis Med; 2017 Oct; 95(10):854-858. PubMed ID: 29873054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
    Laroche S; Scatton O; Charlotte F; Bachet JB; Lim C; Fuks D; Goumard C
    Ann Surg Oncol; 2024 Jul; 31(7):4436-4444. PubMed ID: 38549003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LiMAx Test Improves Diagnosis of Chemotherapy-Associated Liver Injury Before Resection of Colorectal Liver Metastases.
    Lock JF; Westphal T; Rubin T; Malinowski M; Schulz A; Jara M; Bednarsch J; Stockmann M
    Ann Surg Oncol; 2017 Sep; 24(9):2447-2455. PubMed ID: 28516292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The developing clinical problem of chemotherapy-induced hepatic injury.
    Pilgrim CH; Thomson BN; Banting S; Phillips WA; Michael M
    ANZ J Surg; 2012; 82(1-2):23-9. PubMed ID: 22507491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
    Stevenson HL; Prats MM; Sasatomi E
    BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.